Thermo Fisher ScientificBSP:TMOS34 +7.04%74 OCF Margin % is 10.83% as of Mar. 2026, which is 45% below its 10-year median of 19.54. GuruFocus rates BSP:TMOS34 with a GF Score™ of 74/100 and a GF Value™ of R$63.08 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Thermo Fisher Scientific ranks better than 74.51% on this metric.
The historical rank and industry rank for Thermo Fisher Scientific's OCF Margin % or its related term are showing as below:
BSP:TMOS34'
s OCF Margin % Range Over the Past 10 Years
Min: 17.55 Med: 19.54 Max: 25.73
Current: 18.38
During the past 13 years, the highest OCF Margin % of Thermo Fisher Scientific was 25.73%. The lowest was 17.55%. And the median was 19.54%.
BSP:TMOS34's OCF Margin % is ranked better than 74.51% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs BSP:TMOS34: 18.38
Thermo Fisher Scientific OCF Margin % Related Terms
Thermo Fisher Scientific OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:TMOS34 vs DHR, IDXX, A: OCF Margin % Comparison
For the Diagnostics & Research subindustry, Thermo Fisher Scientific's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thermo Fisher Scientific OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Thermo Fisher Scientific's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific (BSP:TMOS34) has a OCF Margin % of 10.83% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Thermo Fisher Scientific and its competitors. This is 45% below median its historical median of 19.54. Over the past decade, Thermo Fisher Scientific's OCF Margin % has ranged from 17.55 to 25.73. According to the industry distribution chart, Thermo Fisher Scientific ranks #52 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 25.5%.
Is Thermo Fisher Scientific's OCF Margin % too high?
Thermo Fisher Scientific's current OCF Margin % of 10.83% is 45% below median its 10-year median of 19.54. Over the past 10 years, this metric has ranged from a low of 17.55 to a high of 25.73. The Medical Diagnostics & Research industry median OCF Margin % is 4.76. Thermo Fisher Scientific's value of 10.83% is 127.8% above this industry median. Based on the distribution chart, Thermo Fisher Scientific ranks #52 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Thermo Fisher Scientific has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's OCF Margin % compare to DHR and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Thermo Fisher Scientific ranks #52 out of 204 companies for OCF Margin %. This puts Thermo Fisher Scientific in the upper half of its industry. The industry median OCF Margin % is 4.76. Thermo Fisher Scientific's value of 10.83% is 127.8% above this benchmark. Historically, Thermo Fisher Scientific's own OCF Margin % has ranged from 17.55 to 25.73 over the past decade. While the company's 10-year median is 19.54 vs. the industry median of 4.76, Thermo Fisher Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Thermo Fisher Scientific's current OCF Margin % of 10.83% is 127.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Thermo Fisher Scientific and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thermo Fisher Scientific's current OCF Margin % is 10.83%, which is 45% below median its own 10-year median of 19.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (BSP:TMOS34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$63.08, compared to a current price of R$53.25 — trading 15.6% below its estimated fair value. The current OCF Margin % is 10.83%, which is 45% below median its 10-year median of 19.54 and 127.8% above the Medical Diagnostics & Research industry median of 4.76. Thermo Fisher Scientific's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Thermo Fisher Scientific (BSP:TMOS34), the current OCF Margin % is 10.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Thermo Fisher Scientific (BSP:TMOS34) Overvalued in 2026?
Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued.
The current stock price of R$53.25 is trading 15.6% below its estimated GF Value™ of R$63.08.
GuruFocus considers Thermo Fisher Scientific to be Modestly Undervalued.
Key valuation signals for BSP:TMOS34:
OCF Margin %: 10.83% (45% below median its 10-year median of 19.54)
GF Value™: R$63.08 vs. price of R$53.25 (15.6% below fair value)
Industry Position: 127.8% above the Medical Diagnostics & Research median (#52 of 204)
No single metric tells the full story. See the BSP:TMOS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
74GF Score
Get the complete analysis for BSP:TMOS34
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:TMOS34 has been successfully added to your 
